A new study in Birth: Issues in Perinatal Care suggests that implementing five breastfeeding-friendly practices in hospitals following birth can significantly improve long-term breastfeeding success.
Compounds in cranberries may help improve the effectiveness of platinum drugs that are used in chemotherapy to fight ovarian cancer, researchers have found in a laboratory study that will be reported today at the 234th national meeting of the American Chemical Society.
National Ovarian Cancer Awareness Month is an opportunity to underscore our commitment to fighting ovarian cancer and to finding a cure for this deadly disease, says George W. Bush, President of USA.
Christmas may come just once a year, but if you are looking for gift ideas that will make an impact long after the decorations have come down, why not give one of Cancer Research UK’s alternative gifts, and help beat cancer at the same time.
Patients with advanced kidney cancer and gastrointestinal stromal tumours in British Columbia will be the first in Canada to benefit from coverage for the medication Sutent (sunitinib) or Nexavar (sorafenib), announced Health Minister George Abbott today.
Eating more cruciferous vegetables like broccoli and cauliflower is associated with a reduced risk of aggressive prostate cancer.
Women who have breast cancer before age 50 and who have few female relatives on one side of their family tree should be considered candidates for genetic testing for cancer genes, say a team of researchers at City of Hope.
Researchers from the University of Pittsburgh School of Medicine report a significant new advance in the search for an effective treatment for human liver cancer in the July issue of Molecular Cancer Therapeutics.
Cancer Research UK funded scientists have for the first time identified a common genetic variant that can increase a person’s risk of developing bowel cancer. Their findings appear in two papers published online in Nature Genetics.
University of Florida and University of Michigan scientists isolated nearly 200 proteins from the urine of patients with and without bladder cancer. Several appear promising as potential biomarkers, including one that studies conducted elsewhere have already linked to liver and ovarian cancer.